Stealth Biotherapeutics Stock Predictions

Healthcare > Biotechnology

Buy MITO

*Your capital is at risk

$0.320

+0 (+0%)

At Close: Feb 14, 2023

Currently predicting for Fri, 5 Jun 2026

MITO Prediction Chart

MITO Predictions History

Latest community submissions for MITO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	May 25, 2021	$1.29 -1.53%	$1.31	X	98.47%	1
Bartenders	May 25, 2021	Bullish	$1.31	X	—	0
JS Pro	Jan 14, 2021	$1.52 +0.66%	$1.51	X	99.34%	4
Billy Phillips @BillyPhillips.183864	Jan 14, 2021	Bullish	$1.51	X	—	0
JS Pro	Dec 28, 2020	$1.58 -2.47%	$1.62	X	97.53%	0
RK	Dec 28, 2020	$2.25 +38.89%	$1.62	X	61.11%	0
JS Pro	Nov 18, 2020	$1.53 +4.08%	$1.47	X	95.92%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MITO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT STEALTH BIOTHERAPEUTICS CORP

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for th...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by